^ abJablonski S (1967). Russian Drug Index. Public Health Service publication. U.S. Department of Health, Education, and Welfare, Public Health Service. p. 245. Retrieved 4 October 2024 – via National Library of Medicine (U.S.). Pyridoxiphen (Piridoksifen). 4-Pyridinemethanol, 3-hydroxy-2-methyl-5-((α-methylphenethyl)amino)methyl)-, dihydrochloride. C17H22N2O2.2HCl. [Structure image.] Product of condensation of phenamine and pyridoxine.. Arbuzov SI, Smirnova SM 1964; Arbuzov SI, Smirnova SM (1964). "Sympatholytic and hypotensive effects of pyridoxiphen". Farmakologiia i toksikologiia. 27: 420–423. PMID14193108.
^ abcDange SA, Adhikari GM (1963). International Socialist Miscellany (in Italian). p. 131. Retrieved 4 October 2024. Our chair has also produced certain derivatives of phenatin which likewise possess valuable qualities. For instance, there is pyridoxiphen, a product of condensation of phenamin and pyridoxine (Vitamin B3). This preparation is necessary in clinical practice for treating some of the diseases of the nervous system. We are persistently looking for even more active stimulators. This calls for a still deeper knowledge of the processes of metabolism in the nervous tissues, processes that lead to the exhaustion of these tissues, This will provide man with a means of conquering fatigue for long.
^Arbuzov SI, Aleksandrova AE, Amirnova SM (1966). "[On the action of pyridoxyphen on central nervous system]" [On the action of pyridoxyphen on central nervous system]. Farmakologiia I Toksikologiia (in Russian). 29 (5): 521–522. PMID5995060.
^Arbuzov SI, Gorodnik AG, Nikiforov MI (1968). "[On the effect of pyridoxiphen on some functions of the nervous system]" [On the effect of pyridoxiphen on some functions of the nervous system]. Farmakologiia I Toksikologiia (in Russian). 31 (2): 152–156. PMID5674665.
^ abAerospace Technology Division, Library of Congress. "CBE Factors Monthly Survey No. 40, ATD Work Assignment No. 50 (ATD Report 69-77-50-10)"(PDF). Retrieved 4 October 2024. Compound I does not display the pronounced hypotensive action characteristic of Pirodoksifen (i.e., pyridoxylamphetamine) and Fenatin (i.e., nicotinoylamphetamine) nor the central stimulating effect of Fenatin.
^ abFitzpatrick WH (1974). Soviet Research in Pharmacology and Toxicology, 1963-1972. DHEW publication no. (NIH) 75-696. National Institutes of Health. pp. 22, 77. Retrieved 4 October 2024. C. Other Drug Effects (32) investigated the action of Arbuzov, Aleksandrova et al. pyridoxyphen, a new adrenolytic, on the central nervous system. Pyridoxyphen, a product of the condensation of phenamine and pyridoxine, exerted no central adrenolytic action. Because of the highly ionic nature of the molecule, the authors concluded that pyridoxyphen was incapable of overcoming the hemato-encephalic barrier.
^Arbuzov SI, Smirnova SM (1964). "Simpatoliticheskoe i gipotenzivnoe de istvie piridoksifena" [Sympatholytic and hypotensive effects of pyridoxiphen]. Farmakologiia I Toksikologiia (in Russian). 27: 420–423. PMID14193108.